Skip to main content

Currently Skimming:

References
Pages 135-158

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 135...
... 2016. Steady increase in prices for oral anticancer drugs after market launch suggests a lack of competitive pressure.
From page 136...
... branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. Health Affairs 32(4)
From page 137...
... Health Affairs 36(3)
From page 138...
... 2013. On access and accountability -- Two Supreme Court rulings on generic drugs.
From page 139...
... 2000. The role of PBMs in managing drug costs: Impli cations for a Medicare drug benefit: Menlo Park, CA: Henry J
From page 140...
... 2007. Prescription drugs: An overview of approaches to negotiate drug prices used by other countries and U.S.
From page 141...
... American Journal of Health Economics 3(1)
From page 142...
... 2006. Extensions of intellectual property rights and delayed adoption of generic drugs: Effects on Medicaid spending.
From page 143...
... 2017. Clini cal trials and systematic reviews addressing similar interventions for the same condition do not consider similar outcomes to be important: A case study in HIV/AIDS.
From page 144...
... 2016. Drugmakers point finger at middlemen for rising drug prices.
From page 145...
... 2015. Specialty drugs: Issues and challenges: Advancing effective strategies to address soaring drug costs while ensuring access to effective treat ments and promoting continued medical innovation.
From page 146...
... 2016. Steady increase in prices for oral anticancer drugs after market launch suggests a lack of competitive pressure.
From page 147...
... Health Affairs 33(10)
From page 148...
... American Journal of Clinical Oncology 39(2)
From page 149...
... 2017f. The Generic Drug Review Dashboard as of April 1, 2017.
From page 150...
... 2016b. Generic drugs under Medicare: Part D generic drug prices declined overall, but some had extraordinary price increases.
From page 151...
... http://www.health affairs.org/do/10.1377/hpb20171409.000175/full. Helmons, P
From page 152...
... 2016. Forces influencing generic drug development in the United States: A narrative review.
From page 153...
... 2011. Hospital pharmacists scrambling amid vast drug shortages.
From page 154...
... 2013. The effect of generic drug competition on generic drug prices during the Hatch–Waxman 180-day exclusivity period.
From page 155...
... 2016. Rx Price Watch Report: Trends in retail prices of brand name prescription drugs widely used by older Americans: 2006 to 2015.
From page 156...
... Health Affairs 35(9)
From page 157...
... Health Affairs 19(2)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.